Respiratory Distress Symptom Intervention (RDSI)
Research type
Research Study
Full title
A randomised controlled trial to determine the clinical and cost effectiveness of the Respiratory Distress Symptom Intervention for people with lung cancer
IRAS ID
204299
Contact name
Janelle Yorke
Contact email
Sponsor organisation
The Christie NHS Foundation Trust
Duration of Study in the UK
2 years, 6 months, 2 days
Research summary
Lung cancer is responsible for 33,000 deaths each year in the UK and as disease cure is rarely possible, patient management is often aimed at symptom control. Breathlessness, cough and fatigue are common and distressing symptoms occurring in up to 90%, 47-86% and 50-90% of patients respectively. To date, research in relation to this group of symptoms has focussed on breathlessness, cough or fatigue as single symptoms. However, it is likely that if a patient suffers from one symptom, they also suffer from one or both of the others. Collectively these symptoms are referred to as the Respiratory Distress Symptom Cluster.
Our group has developed a multi-modal Respiratory Distress Symptom Intervention (RDSI) for the self management of breathlessness, cough and fatigue. This study aims to determine the effects of adding the RDSI to usual care for the self-management of the Respiratory Distress Symptom Cluster for patients with lung cancer.
Patients who take part will be assigned to one of two groups; usual care or usual care plus the RDSI.
REC name
North West - Greater Manchester Central Research Ethics Committee
REC reference
16/NW/0718
Date of REC Opinion
21 Oct 2016
REC opinion
Favourable Opinion